BMJ talk medicine

Welcome back to the Thorax Podcast, home to the discussion of new research and hot topics in respiratory research and clinical practice. In this first episode, we introduce you to the three new Editors of the Thorax journal: Dr. Mark Griffiths and Dr. Jennifer Quint, both from Imperial College London, and Dr. Cecilia O'Kane, from Queen's University Belfast. They outline plans for the Thorax journal, including the social media strategy and engaging readers and trainees.

You'll also get to know a bit more about the two new social media editors of the journal, Dr. Puja Mehta, from University College London and Dr. Kate Diomede from Imperial College London, whose voices you'll get very familiar with over the coming months, as they are our two new podcast hosts.

Please engage in the conversation through the social media channels (Twitter - @ThoraxBMJ; Facebook - @Thorax.BMJ · Pulmonologist) and subscribe on your preferred platform, to get the latest episodes directly on your device each month.

If you enjoy the Thorax Podcast, please leave us a rating and a review on the Thorax Podcast page on iTunes - https://podcasts.apple.com/gb/podcast/thorax-podcast/id343304910.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Paolo Zola to discuss the TOTEM trial. For 20 years, Dr. Zola has been Chair of Gynaecological Oncology in the Department of Surgical Sciences of the University of Turin (Italy). Dr. Zola has conducted a large number of national and international randomized clinical trials in order to optimize the treatments for women diagnosed with gynaecological cancers. He has served as a member of the board of the EORTC Gynaecological Cancer Group and of the ESGO. Dr. Zola chairs the gynaecological cooperative group within the Oncological Network in Piedmont Region, and his research has been reported in more than 400 manuscripts published in peer reviewed literature.

Highlights:

- To perform the follow up in patients treated for endometrial cancer, the cornerstone is the clinical control.

- In low-risk patients, surveillance every 6 months is appropriate.

- In high-risk patients a clinical examination every 4 months for 2 years and then every 6 is recommended.

- In addition, our data suggest taking a CT after 12 and 20 months after the primary treatment.

Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.

In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatment uncertainty, put paid to conservative prescribing; and what innovations in microbial treatment are on the horizon.

Following that, James Campbell, director of the health workforce department at the WHO, who joins us to talk about new data they have on the wellbeing, and why the international market for healthcare staff is no longer the simple solution for vacancies.

The BMJ's collections we mentioned are on empowering and engaging patients (https://www.bmj.com/empowering-and-engaging-patients) and food security and health in a changing environment (https://www.bmj.com/food-security-and-health-in-a-changing-environment)

This week, we’re joined by Huseyin Naci to discuss the recent press release from Eisai and Biogen announcing the Phase III trial results for lecanemab for use in Alzheimer’s disease, and the FDA’s decision to accept the drug onto its accelerated approval pathway. We talk about the pros and cons of using surrogate endpoints to predict clinical outcomes. How can we strike a better balance in clinical trials between generating high-quality and trustworthy evidence, and the urgent needs of patients with life-limiting conditions and very few available treatment options?

Our guest:

Huseyin Naci is an associate professor of Health Policy at the London School of Economics and Political Science (LSE). He is also an advisor to the Analysis section of The BMJ.

Exercise Medicine and Physical Activity Promotion with Dr. Irfan Asif EP# 519

On this episode of the AMSSM Sports Medcast, host Dr. Devin McFadden, MD, is joined by Dr. Irfan Asif, MD, to discuss the topic of Exercise Medicine and Physical Activity Promotion.

Dr. Asif, who is the Chair of the AMSSM Collaborative Research Network, helped lead the 2021 Research Summit, which produced several publications and educational resources related to Exercise Medicine and Physical Activity Promotion. In this conversation, he addresses the following topics and questions:

• A refresher on the 2021 Research Summit and the significant outcomes from that event

• How the Exercise Medicine and Physical Activity Promotion Core Curricula originated

• More details about the interactive and freely available Exercise Medicine & Physical Activity Promotion Modules

• How can physicians and other medical faculty integrate these resources into their clinical practices?

• Providing information about the upcoming 2023 Research Summit on Justice, Equity and Inclusion, which takes place in April 2023

• Future publications, deliverables and other opportunities stemming from the 2021 Research Summit

Additional Resources

Exercise Medicine & Physical Activity Promotion Modules tinyurl.com/exercisemodules

Exercise Medicine and Physical Activity Promotion: Core Curricula for US Medical Schools, Residencies and Sports Medicine Fellowships https://bjsm.bmj.com/content/bjsports/56/7/369.full.pdf

In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB.

In this podcast, David Phizackerley (DTB's deputy editor) talks to Dr Jo Congleton, who is a consultant in Integrated Respiratory Care in Brighton and Hove. She is also clinical lead for the Kent, Surrey, Sussex Academic Health and Science Network (AHSN) Respiratory Programme. Her interests are in chronic respiratory conditions (particularly COPD) and reducing both variation, and inequalities, in care.

This special series of the DTB Podcast is produced by Leticia Amorim.

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.

Accents and dialects are influenced by so many different things including race, gender, and class. They change frequently depending on where we are, who we are with, and even what we are trying to get out of any given interaction. But why does this happen? Do we gravitate towards a certain accent in order to fit in?

In this episode, we'll find out what an accent actually is, we'll discuss how our accents have changed whilst we've been at university, and we'll also examine the judgement that can arise when you speak in a ‘different’ accent to what someone else is used to.

Expert guests:

Lisa Casey is an Assistant Principal in a secondary school in London with a background in English and literacy. She is one of the hosts of Lexis, a podcast about language and linguistics for A Level students, teachers and anyone else who's interested in language.

Check us out on social media:

Twitter: https://twitter.com/BMJStudent

Instagram: https://www.instagram.com/bmj_student/

Facebook: https://www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

The moving story of an English professor studying neurology in order to understand and come to terms with her father's death from Alzheimer's. Brandy Schillace (Medical Humanities' Editor-in-Chief) interviews Cindy Weinstein, Vice Provost and Professor of English at California Institute of Technology.

Related blog including the transcription of the podcast:

https://blogs.bmj.com/medical-humanities/2022/11/08/cindy-weinstein/

Subscribe to the Medical Humanities Podcast in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you for listening!

We release episodes fortnightly. Parkinson's disease is a common and serious condition. It is the second most common neurodegenerative disorder in the world - only Alzheimer's disease is more common. And Parkinson's disease can cause a range of complications - from dyskinesias to depression to dementia. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast, Kieran Walsh talks to Delaram Safarpour, Assistant Professor of Neurology at Oregon Health & Science University.

Competing interests: DS has received honoraria for participation in advisory boards for Boston Scientific (the manufacturer of Deep Brain Stimulation devices) and Abbvie (the manufacturer of Duopa). She has received consultation fees from Abbott (the manufacturer of Deep Brain Stimulation devices). DS has received an institutional grant and has received an honorarium for lectures from the Parkinson’s Study Group.

In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Matthew Amans(1) and Daniel Cummins(2) about their paper "Cerebrovascular pulsatile tinnitus: causes, treatments, and outcomes in 164 patients with neuroangiographic correlation" - https://jnis.bmj.com/content/early/2022/09/08/jnis-2022-019259.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767

Thank you for listening!

This episode was edited by Brian O'Toole.

(1) School of Medicine, University of California, San Francisco, USA

(2) Radiology and Biomedical Imaging, University of California, San Francisco, USA